Profound Medical previews Q3 2026 revenue and gross margin
Profound Medical reported preliminary unaudited Q3 2026 revenue of $9.8M to $10.0M, with year-over-year growth of about 85% to 89% and gross margin expected to exceed 70%. Sequential revenue rose about 292% to 300% versus Q2 2026.
0 million, up about 85%—89% from a year earlier and roughly 45%—47% above Bloomberg consensus. The company said sequential revenue increased roughly 292%—300% versus Q2 2026, with gross margin again expected…